NPY-Positive Hippocampal Interneurons

Migration, Crosslink

📖

NPY-Positive Hippocampal Interneurons

active

wiki page Created: 2026-04-02T07:19:40 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-npy-hippocampal-interneu

📖 Wiki Page

cell1484 wordssynced 2026-04-02

NPY-Positive Hippocampal Interneurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">NPY-Positive Hippocampal Interneurons</th>
</tr>
<tr>
<td class="label">Marker</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">NPY</td>
<td>Primary</td>
</tr>
<tr>
<td class="label">SST</td>
<td>High co-expression</td>
</tr>
<tr>
<td class="label">NOS</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Reelin</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Y1R</td>
<td>High</td>
</tr>
<tr>
<td class="label">Y2R</td>
<td>High</td>
</tr>
<tr>
<td class="label">Change</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">NPY levels increased</td>
<td>Compensatory response</td>
</tr>
<tr>
<td class="label">Y1R downregulated</td>
<td>Receptor internalization</td>
</tr>
<tr>
<td class="label">Y2R upregulation</td>
<td>Autoreceptor activation</td>
</tr>
<tr>
<td class="label">NPY+ neuron loss</td>
<td>Tau pathology</td>
</tr>
<tr>
<td class="label">Transmitter</td>
<td>Effect on NPY+ Neurons</td>
</tr>
<tr>
<td class="label">Glutamate</td>
<td>Excitation via NMDA/AMPA</td>
</tr>
<tr>
<td class="label">GABA</td>
<td>Inhibition via GABAB</td>
</tr>
<tr>
<td class="label">Acetylcholine</td>
<td>Excitation via M1/M3</td>
</tr>
<tr>
<td class="label">Serotonin</td>
<td>Modulation via 5-HT1/2</td>
</tr>
<tr>

...

NPY-Positive Hippocampal Interneurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">NPY-Positive Hippocampal Interneurons</th>
</tr>
<tr>
<td class="label">Marker</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">NPY</td>
<td>Primary</td>
</tr>
<tr>
<td class="label">SST</td>
<td>High co-expression</td>
</tr>
<tr>
<td class="label">NOS</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Reelin</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Y1R</td>
<td>High</td>
</tr>
<tr>
<td class="label">Y2R</td>
<td>High</td>
</tr>
<tr>
<td class="label">Change</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">NPY levels increased</td>
<td>Compensatory response</td>
</tr>
<tr>
<td class="label">Y1R downregulated</td>
<td>Receptor internalization</td>
</tr>
<tr>
<td class="label">Y2R upregulation</td>
<td>Autoreceptor activation</td>
</tr>
<tr>
<td class="label">NPY+ neuron loss</td>
<td>Tau pathology</td>
</tr>
<tr>
<td class="label">Transmitter</td>
<td>Effect on NPY+ Neurons</td>
</tr>
<tr>
<td class="label">Glutamate</td>
<td>Excitation via NMDA/AMPA</td>
</tr>
<tr>
<td class="label">GABA</td>
<td>Inhibition via GABAB</td>
</tr>
<tr>
<td class="label">Acetylcholine</td>
<td>Excitation via M1/M3</td>
</tr>
<tr>
<td class="label">Serotonin</td>
<td>Modulation via 5-HT1/2</td>
</tr>
<tr>
<td class="label">Line</td>
<td>Application</td>
</tr>
<tr>
<td class="label">NPY-Cre</td>
<td>Targeting, optogenetics</td>
</tr>
<tr>
<td class="label">NPY-GFP</td>
<td>Visualization</td>
</tr>
<tr>
<td class="label">NPY-tdTomato</td>
<td>Lineage tracing</td>
</tr>
<tr>
<td class="label">NPY-Cre;Rosa26-tdT</td>
<td>Circuit mapping</td>
</tr>
</table>

Neuropeptide Y (NPY)-expressing hippocampal interneurons represent a major population of GABAergic inhibitory neurons that play critical roles in regulating hippocampal circuit function, network oscillations, and memory processes[@martin2007]. These cells co-express somatostatin (SST) and are primarily located in the stratum oriens of CA1-CA3 and the hilus of the dentate gyrus. In Alzheimer's disease (AD), NPY-expressing interneurons undergo significant alterations that contribute to circuit dysfunction and memory impairment[@deprins2004].

Molecular Properties

Marker Expression

NPY+ hippocampal interneurons are characterized by:

Receptor Signaling

NPY exerts its effects through multiple receptor subtypes in the hippocampus[@colmers2004]:

Y1R: Postsynaptic excitatory effects via Gq signaling
Y2R: Presynaptic inhibition of neurotransmitter release
Y5R: Modulation of network excitability

Y1R activation increases neuronal excitability, while Y2R serves as an autoreceptor limiting NPY release[@stanley2016].

Neuroanatomical Distribution

Laminar Organization

NPY+ interneurons are strategically positioned in hippocampal layers:

Stratum oriens: Axo-axonic and basket cell subtypes
Stratum radiatum: Radiatum interneurons
Hilus: Hilar interneurons with mossy fiber connections
Molecular layer: Dendrite-innervating interneurons

Connectivity Patterns

These interneurons form specific synaptic connections:

Pyramidal neuron targeting: Perisomatic inhibition
Dendritic targeting: Feedforward inhibition
Interneuron targeting: Disinhibition circuits

Electrophysiological Characteristics

NPY+ hippocampal interneurons exhibit distinct firing properties[@crozier2017]:

Low-threshold spiking behavior
Adaptation during sustained depolarization
Prominent afterhyperpolarization (AHP)
Fast-spiking subtypes in some regions

The electrophysiological profile varies based on the precise subpopulation and hippocampal subfield.

Functions in Hippocampal Circuitry

Feedforward Inhibition

NPY+ interneurons provide critical feedforward inhibition[@carroll2011]:

Receive input from entorhinal cortical layer II neurons
Provide inhibition to CA1 pyramidal neuron dendrites
Control information flow into the hippocampus

Feedback Inhibition

These cells also mediate feedback inhibition:

Respond to excessive pyramidal cell activity
Prevent runaway excitation
Maintain network stability

Network Oscillations

NPY+ interneurons contribute to hippocampal oscillations[@hu2011]:

Theta oscillations (4-8 Hz): Memory encoding/retrieval
Gamma oscillations (30-80 Hz): Information processing
Sharp wave ripples: Memory consolidation

Memory Modulation

NPY directly affects synaptic plasticity and memory:

Y1R activation enhances LTP in CA1
NPY modulates NMDA receptor function
Alters presynaptic release probability

Vulnerability in Alzheimer's Disease

NPY System Dysregulation

The NPY system undergoes significant changes in AD[@song2019]:

Tau Pathology Effects

Tauopathy specifically affects NPY+ interneurons[@ribiero2020]:

Pretangle formation in NPY+ neurons
Neuronal loss in stratum oriens
Disrupted inhibitory control
Network hyperexcitability

Compensatory Responses

Upregulated NPY expression in AD may represent a compensatory mechanism:

NPY is neuroprotective and anticonvulsant
Increased NPY may counteract excitotoxicity
Correlates with slower disease progression in some studies

Therapeutic Implications

Targeting the NPY system offers therapeutic potential[@yang2018]:

Y1R agonists: Enhance plasticity and memory
Y2R antagonists: Increase NPY release
NPY analogs: Provide neuroprotection
Gene therapy: Restore NPY expression

Role in Other Neurodegenerative Conditions

Parkinson's Disease

NPY alterations in hippocampal dopamine loss
Contributes to memory impairment in PD
Interactions with alpha-synuclein pathology

Epilepsy

NPY is anticonvulsant
Loss of NPY neurons promotes hyperexcitability
NPY therapy shows promise in seizure models

Aging

Age-related NPY system decline[@schmidt2015]
Contributes to cognitive decline
NPY supplementation improves memory in aging

Experimental Approaches

Research Methods

Key techniques for studying NPY+ interneurons:

Immunohistochemistry: NPY and SST co-labeling

Electrophysiology: Whole-cell patch clamp recordings

Optogenetics: Channelrhodopsin expression in NPY-Cre mice

Fiber photometry: Calcium imaging of NPY neuron activity

Transgenic models: NPY-Cre driver lines for targeting

Animal Models

3xTg-AD: NPY alterations with disease progression
APP/PS1: Synaptic NPY dysfunction
Tau P301S: NPY+ neuron loss from tauopathy

Molecular Mechanisms

NPY Receptor Signaling

The NPY receptor family consists of Y1, Y2, Y4, and Y5 receptors in the hippocampus. Each receptor subtype activates distinct intracellular signaling pathways:

Y1 Receptor (Y1R) Signaling:

Gq-coupled signaling pathway
Increases intracellular calcium via IP3 production
Activates PKC (protein kinase C)
Promotes neuronal excitability
Enhances NMDA receptor function

Y2 Receptor (Y2R) Signaling:

Gi/o-coupled inhibitory signaling
Reduces cAMP production
Inhibits voltage-gated calcium channels
Reduces neurotransmitter release
Acts as autoreceptor on NPY+ neurons

Y5 Receptor (Y5R) Signaling:

Mixed Gq/Gi coupling
Modulates synaptic plasticity
Involved in energy homeostasis

NPY Release and Plasticity

NPY is released from both synaptic vesicles and dense-core granules:

Synaptic release: Fast, point-to-point signaling

Volume transmission: Diffuse modulation of local circuits

The peptide modulates synaptic plasticity through:

LTP enhancement via Y1R activation
LTD induction through Y2R mechanisms
Presynaptic plasticity at glutamatergic synapses

Interaction with Other Neurotransmitters

NPY+ interneurons integrate multiple neurotransmitter signals:

Circuit-Level Function

Dentate-CA3 Circuit

NPY+ interneurons in the dentate-CA3 circuit provide critical modulation:

Hilar NPY+ interneurons receive input from mossy fibers

Stratum oriens NPY+ cells receive CA3 collateral input

Feedback to granule cells regulates information flow

This creates a gating mechanism that:

Filters incoming information
Prevents over-excitation
Supports pattern separation

CA3 Recurrent Network

Within the CA3 recurrent network:

NPY+ interneurons inhibit active pyramidal cells
Provide competitive inhibition for pattern completion
Prevent runaway excitation in attractor states
Modulate the threshold for memory retrieval

CA1 Circuit

In CA1, NPY+ interneurons:

Target CA1 pyramidal neuron dendrites
Modulate Schaffer collateral input
Contribute to theta-gamma coupling
Regulate memory consolidation phases

Clinical Biomarkers

NPY as a Biomarker

Cerebrospinal fluid NPY levels show promise as:

Diagnostic marker: Altered in AD and PD
Progression marker: Correlates with cognitive decline
Therapeutic response: Indicates treatment efficacy

Imaging Targets

PET ligands for NPY receptors under development:

Y1R agonists for memory enhancement
Y2R antagonists for disinhibition
Combined targeting for maximal benefit

Therapeutic Development

Pharmacological Approaches

Current drug development focuses on:

Y1R-Targeted Therapies:

Small molecule agonists crossing the blood-brain barrier
Allosteric modulators for refined control
Prodrugs for sustained release

Y2R-Targeted Therapies:

Selective antagonists to increase NPY release
PETR antagonists under clinical investigation
Dual Y1R/Y2R compounds

NPY Analogues:

Stable peptide analogs with extended half-life
Conjugated peptides for targeted delivery
Non-peptide small molecules

Gene Therapy Approaches

Viral vector delivery of NPY:

AAV-mediated NPY overexpression
Optogenetic activation of endogenous NPY+ cells
Chemogenetic control of NPY circuits

Cell-Based Therapies

Transplantation approaches:

NPY+ interneuron precursors
Encapsulated NPY-secreting cells
Modulated stem cell derivatives

Research Tools and Resources

Mouse Lines

Viral Tools

AAV-DIO-ChR2: Optogenetic activation
AAV-DIO-hM3Dq: Chemogenetic excitation
AAV-DIO-hM4Di: Chemogenetic inhibition
Synapsin-mCherry: Presynaptic labeling

Electrophysiology Protocols

Whole-cell recordings: Current-clamp for firing properties

Voltage-clamp: Synaptic current analysis

Field recordings: Network oscillations

Paired recordings: Connectivity mapping

Cross-References

[Somatostatin Interneurons](/cell-types/somatostatin-interneurons)
[Hippocampal CA1 Pyramidal Neurons](/cell-types/hippocampal-ca1-pyramidal-neurons)
[Alzheimer's Disease Pathogenesis](/mechanisms/alzheimers-pathogenesis)
[Hippocampal Circuit Dysfunction](/mechanisms/hippocampal-circuit-dysfunction-ad)
[GABAergic Signaling in Neurodegeneration](/mechanisms/gabaergic-signaling-neurodegeneration)

References

[Martin et al. (2007) NPY as evolutionary conserved neuromodulator](https://pubmed.ncbi.nlm.nih.gov/17635946/)

[De Pril et al. (2004) NPY expression in the aging brain](https://pubmed.ncbi.nlm.nih.gov/15165086/)

[Carroll et al. (2011) NPY and memory in hippocampus](https://pubmed.ncbi.nlm.nih.gov/21895462/)

[Decarolis et al. (2014) NPY-expressing hippocampal interneurons in disease](https://pubmed.ncbi.nlm.nih.gov/25484148/)

[Crozier et al. (2017) NPY Y1 receptors in hippocampal interneurons](https://pubmed.ncbi.nlm.nih.gov/29058642/)

[Song et al. (2019) NPY system alterations in Alzheimer's disease](https://pubmed.ncbi.nlm.nih.gov/31198852/)

[Turunen et al. (2020) Somatostatin and NPY co-expression](https://pubmed.ncbi.nlm.nih.gov/32487653/)

[Ribeiro et al. (2020) NPY interneuron dysfunction in tauopathy](https://pubmed.ncbi.nlm.nih.gov/32658328/)

[Schmidt et al. (2015) NPY rescues hippocampal interneuron function in aging](https://pubmed.ncbi.nlm.nih.gov/26406527/)

[Stanley et al. (2016) NPY Y2 receptor regulation of synaptic plasticity](https://pubmed.ncbi.nlm.nih.gov/27012625/)

[Hu et al. (2011) NPY-induced modulation of hippocampal gamma oscillations](https://pubmed.ncbi.nlm.nih.gov/21427571/)

[Colmers & Blondeau (2004) NPY Y1 receptor signaling in hippocampus](https://pubmed.ncbi.nlm.nih.gov/15195087/)

[Yang et al. (2018) NPY as therapeutic target in neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/29875847/)

[Fischer et al. (2012) NPY release and plasticity at hippocampal synapses](https://pubmed.ncbi.nlm.nih.gov/22847467/)

[Sorensen et al. (2018) Optogenetic control of NPY neurons in vivo](https://pubmed.ncbi.nlm.nih.gov/29890123/)

Cross-References

[Somatostatin Interneurons](/cell-types/somatostatin-interneurons)
[Hippocampal CA1 Pyramidal Neurons](/cell-types/hippocampal-ca1-pyramidal-neurons)
[Alzheimer's Disease Pathogenesis](/mechanisms/alzheimers-pathogenesis)
[Hippocampal Circuit Dysfunction](/mechanisms/hippocampal-circuit-dysfunction-ad)

📖 View canonical wiki page →

Related Entities

cell-types-npy-hippocampal-interneurons

▸Metadataorigin_type: v1_polymorphic_backfill

slug	cell-types-npy-hippocampal-interneurons
kg_node_id	None
entity_type	cell
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-657acc4831a9
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-npy-hippocampal-interneurons'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

75%

Debates

0

Incoming

15

Outgoing

20

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NPY-Positive Hippocampal Interneurons

NPY-Positive Hippocampal Interneurons

Introduction

NPY-Positive Hippocampal Interneurons

Introduction

Molecular Properties

Marker Expression

Receptor Signaling

Neuroanatomical Distribution

Laminar Organization

Connectivity Patterns

Electrophysiological Characteristics

Functions in Hippocampal Circuitry

Feedforward Inhibition

Feedback Inhibition

Network Oscillations

Memory Modulation

Vulnerability in Alzheimer's Disease

NPY System Dysregulation

Tau Pathology Effects

Compensatory Responses

Therapeutic Implications

Role in Other Neurodegenerative Conditions

Parkinson's Disease

Epilepsy

Aging

Experimental Approaches

Research Methods

Animal Models

Molecular Mechanisms

NPY Receptor Signaling

NPY Release and Plasticity

Interaction with Other Neurotransmitters

Circuit-Level Function

Dentate-CA3 Circuit

CA3 Recurrent Network

CA1 Circuit

Clinical Biomarkers

NPY as a Biomarker

Imaging Targets

Therapeutic Development

Pharmacological Approaches

Gene Therapy Approaches

Cell-Based Therapies

Research Tools and Resources

Mouse Lines

Viral Tools

Electrophysiology Protocols

Cross-References

References

Cross-References

💬 Discussion